Icon

Inlyta - (1mg, 5mg; Tablet, Oral)

Axitinib Pfizer
1mg, 5mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
Indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
Yes
****** ** *** ***** ** **** **** ** **** ****** '*** (*** **, ****) *** *** ************ *********. ***** *** *** ***** ******* ********** ****** *.*. ******* '***(***** **, ****) & '*** (**** **, ****). ** ** ********* ** **** **** ****** ***** **** *** **** ***** *** ******* *** ***** ****** ****** *** ******* ****** ***** **, ****. ********* ** ******'* *** ******, ******'* *.*. ***** ******* ****** ********** **** ** ******. **, **** ** *** ******** *** ****** *** ******* ****** ******.
Inlyta Patent 1 Patent 2 Patent 3
****** **** *** **** *** *********
******** *** ********* *** ********* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* *** **, **** ******* ********* ******** ******* *** **** *** *** ****
******** ** \ ** *** **, **** ******* ********* ******** ******* *** **** *** *** ****
  1. *** **, **** : ****** ******** ****** ***** *** **** ** **** ****** '*** (*** **, ****).
  2. *** **, **** : ****** ***** * **** ******* ****** ** ******** ***** ** ********.
  3. *** **, **** : ******** ******** ****** ***** *** **** ** **** ****** '*** (*** **, ****).
  4. *** **, **** : ****** ***** * **** ******* ******** ** ****** '*** (*** **, ****)
  5. *** **, **** : ********** ********* **** ****** ** ****** '*** (*** **, ****)
  6. *** **, **** : ****** ********* ********** **** ********. ** ****** **'* * **********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.